Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 112 Breast Neoplasms 17 Neoplasms 7 Leiomyoma 6 Prostate Adenocarcinoma 3 Polycystic Ovary Syndrome 3 Salivary Gland Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Uveal Melanoma 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sleep Apnea, Obstructive 1 Skin Neoplasms 1 Sexual Dysfunctions, Psychological 1 Sexual Dysfunction, Physiological 1 Salivary Gland Neoplasm Duct 1 Recurrence 1 Puberty, Precocious 1 Primary Dysautonomias 1 Premenopausal Breast Cancer 1 Patient Compliance 1 PSA Level Greater Than Two 1 Obesity, Morbid 1 Obesity 1 Myofibroma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Metabolic Syndrome 1 Melanoma 1

Interventions

Urine Specimen Collection 1 Surveys and Questionnaires 1 Robotic Surgical Procedures 1 Metformin 1 Mammography 1 Leuprolide 1 Laparoscopy 1 Interviews as Topic 1 Hepatectomy 1 Blood Specimen Collection 1 Biopsy 1 Bariatric Surgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Obesity, Morbid × Leuprolide × Clear all

NCT04331717 2022-05-02

BASH-PC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Obesity, Morbid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡